Modeling Clinical Trial Attrition Using Machine Intelligence: A driver analytics case study using 1,325 trials representing one million patients

Emmette Hutchison, Youyi Zhang, Sreenath Nampally, Imran Khan Neelufer, Vlad Malkov, Jim Weatherall, Faisal Khan, Khader Shameer
doi: https://doi.org/10.1101/2021.11.12.21266277

Article Information

doi 
https://doi.org/10.1101/2021.11.12.21266277
History 
  • November 14, 2021.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.

Author Information

  1. Emmette Hutchison1,^,
  2. Youyi Zhang1,^,
  3. Sreenath Nampally1,^,
  4. Imran Khan Neelufer2,
  5. Vlad Malkov1,3,
  6. Jim Weatherall2,
  7. Faisal Khan1 and
  8. Khader Shameer1,*
  1. 1Artificial Intelligence & Analytics, Data Science & Artificial Intelligence, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA
  2. 2Data Science & Artificial Intelligence, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK
  3. 3Gilead Sciences, Foster City, CA, USA
  1. ↵*Corresponding author: shameer.khader{at}astrazeneca.com

  1. ↵^ Equal contributors

Back to top
Posted November 14, 2021.
Download PDF

Supplementary Material

Data/Code
Email
Modeling Clinical Trial Attrition Using Machine Intelligence: A driver analytics case study using 1,325 trials representing one million patients
Emmette Hutchison, Youyi Zhang, Sreenath Nampally, Imran Khan Neelufer, Vlad Malkov, Jim Weatherall, Faisal Khan, Khader Shameer
medRxiv 2021.11.12.21266277; doi: https://doi.org/10.1101/2021.11.12.21266277
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area